'Hemoglobin a1c' presentation slideshows

Ambulatory: Diabetes Mellitus

Ambulatory: Diabetes Mellitus. April 9, 2007. Subtypes. Insulin dependent (Type 1 /IDDM) Abrupt onset, < 30 yrs Autoimmune insulin deficiency due to islet cell destruction Prone to ketoacidosis Non-insulin dependent (Type 2/NIDDM) Gradual onset, > 30 yrs Obesity Insulin resistance

758 views • 60 slides

Journal Club

Journal Club. Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mozenson O, McGuire DK, Ray KK, Leiter LA, Raz I; the SAVOR-TIMI 53 Steering Committee and Investigators.

678 views • 46 slides

Tracking Healthy People 2010 Objectives: Methodological and Definitional Changes

Tracking Healthy People 2010 Objectives: Methodological and Definitional Changes. Kathleen M. Turczyn, MPH National Center for Health Statistics. Changes in tracking data can be due to:. Coding classifications (ICD-9 to ICD-10) Revised OMB standards (1997) for race and ethnicity categories

340 views • 33 slides

317 views • 22 slides

475 views • 15 slides

Diabetone Plus

Diabetone Plus is a complete herbal, vitamin, and mineral product that supports healthy blood sugar metabolism. Diabetone Plus. Key Ingredients.

216 views • 6 slides

Diabetes Care Technologies, Devices and Therapeutics Market

Diabetes care market comprises of technologies, devices and therapeutics markets in relation to diabetes. As estimated by The World Diabetes Foundation, there would be 438 million people suffering from diabetes by 2030. Approximately 11.6% of the global healthcare expenditure is shared by diabetes care. In 2010, global expenditure on diabetes was $376 billion. Global diabetes management product market was valued $41 billion in 2012. Sedentary lifestyle and obesity are primary factors driving the diabetes care market. There has been a considerable rise in the number of diabetes cases globally over the last few years. Improper diet and sedentary lifestyle are the main risk-elevating factors. Currently, about 528.7 million people are suffering from obesity, which is a primary reason for development of diabetes in people. Complete Report is Available At: http://www.researchbeam.com/diabetese-care-technologies-devices-therpeutics-market

238 views • 5 slides